Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by AOP Health
AOP Health on Rare Diseases: Information. Collaboration. Innovation.
February 23, 2026
From
AOP Health
Via
Business Wire
AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies
January 12, 2026
From
AOP Health
Via
GlobeNewswire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
December 07, 2025
From
AOP Health
Via
Business Wire
ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
February 17, 2025
From
AOP Health
Via
Business Wire
AOP Health: Completed Study Strengthens Clinical Development Program for ropeginterferon alpha 2b (Besremi®) in polycythaemia vera
June 01, 2023
From
AOP Health
Via
Business Wire
AOP Health Presents New Findings Regarding Consistent Hematologic Response of Patients With polycythaemia vera
May 11, 2023
From
AOP Health
Via
Business Wire
AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting
December 13, 2022
From
AOP Health
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.